153 related articles for article (PubMed ID: 1983804)
21. Is an effective HIV vaccine feasible?
Cohen J
Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
[No Abstract] [Full Text] [Related]
22. AIDS vaccine predictions.
Barin F
Nature; 1987 Jul 2-8; 328(6125):21. PubMed ID: 3474526
[No Abstract] [Full Text] [Related]
23. [The infection and immunity of HIV: hope and thought].
Shang H
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
[No Abstract] [Full Text] [Related]
24. AIDS 1995. Vaccines and immunology: overview.
Montelaro RC; Wigzell H
AIDS; 1995; 9 Suppl A():S111-2. PubMed ID: 8819577
[No Abstract] [Full Text] [Related]
25. AIDS vaccine.
Minn Med; 1991 Mar; 74(3):46. PubMed ID: 2030681
[No Abstract] [Full Text] [Related]
26. Toward an understanding of the correlates of protective immunity to HIV infection.
Haynes BF; Pantaleo G; Fauci AS
Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
[TBL] [Abstract][Full Text] [Related]
27. Trick and treat: toward peptide mimic vaccines.
Shikhman AR; Cunningham MW
Nat Biotechnol; 1997 Jun; 15(6):512-3. PubMed ID: 9181569
[No Abstract] [Full Text] [Related]
28. AIDS response.
Nature; 1991 Dec; 354(6353):439-40. PubMed ID: 1684222
[No Abstract] [Full Text] [Related]
29. Urgently needed: a filter for the HIV-1 vaccine pipeline.
Moore JP; Burton DR
Nat Med; 2004 Aug; 10(8):769-71. PubMed ID: 15286768
[TBL] [Abstract][Full Text] [Related]
30. [HIV without AIDS but no AIDS without HIV].
Soriano V; González-Lahoz J
Med Clin (Barc); 1995 Jul; 105(5):172-3. PubMed ID: 7630229
[No Abstract] [Full Text] [Related]
31. DNA vaccines against human immunodeficiency virus type 1.
Estcourt MJ; McMichael AJ; Hanke T
Immunol Rev; 2004 Jun; 199():144-55. PubMed ID: 15233732
[TBL] [Abstract][Full Text] [Related]
32. Quest for an effective AIDS vaccine takes a new tack.
Maurice J
Lancet; 2011 Jul; 378(9787):213-4. PubMed ID: 21770060
[No Abstract] [Full Text] [Related]
33. Status of HIV vaccine development.
Minor JR
Am J Hosp Pharm; 1994 Jul; 51(14):1816-8. PubMed ID: 7942913
[No Abstract] [Full Text] [Related]
34. The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
McMichael A; Hanke T
Nat Rev Immunol; 2002 Apr; 2(4):283-91. PubMed ID: 12001999
[TBL] [Abstract][Full Text] [Related]
35. Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virus.
Roos MT; Miedema F; Eeftinck Schattenkerk JK; de Wolf F; Goudsmit J; Lange JM; Danner SA; Out TA; Schellekens PT
Neth J Med; 1989 Apr; 34(3-4):132-41. PubMed ID: 2524673
[TBL] [Abstract][Full Text] [Related]
36. Mucosal gatekeepers: selecting HIV viruses for early infection.
Bomsel M; David V
Nat Med; 2002 Feb; 8(2):114-6. PubMed ID: 11821891
[No Abstract] [Full Text] [Related]
37. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
38. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
Betts MR; Gray CM; Cox JH; Ferrari G
Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
[TBL] [Abstract][Full Text] [Related]
39. [Immunopathogenesis and therapeutic approaches in acquired immunologic deficiency syndrome (AIDS)].
Zielinski C
Acta Med Austriaca; 1987; 14(1):5-9. PubMed ID: 2956821
[TBL] [Abstract][Full Text] [Related]
40. Animal models for the study of human immunodeficiency virus infections.
Letvin NL
Curr Opin Immunol; 1992 Aug; 4(4):481-5. PubMed ID: 1356349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
